|
gptkbp:instanceOf
|
gptkb:insulin
|
|
gptkbp:administeredBy
|
subcutaneous injection
|
|
gptkbp:approvedBy
|
gptkb:FDA
2005
|
|
gptkbp:ATCCode
|
A10AE05
|
|
gptkbp:availableOn
|
gptkb:FlexPen
vial
|
|
gptkbp:brand
|
gptkb:insulin_detemir
|
|
gptkbp:chemicalClass
|
long-acting insulin analogue
|
|
gptkbp:contraindication
|
hypersensitivity to insulin detemir
|
|
gptkbp:duration
|
up to 24 hours
|
|
gptkbp:form
|
solution for injection
|
|
gptkbp:halfLife
|
5-7 hours
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Levemir
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Novo_Nordisk
|
|
gptkbp:marketedIn
|
gptkb:Australia
gptkb:Canada
gptkb:European_Union
gptkb:United_States
|
|
gptkbp:mechanismOfAction
|
regulates glucose metabolism
|
|
gptkbp:pregnancyCategory
|
B (US)
|
|
gptkbp:prescriptionRequired
|
yes
|
|
gptkbp:routeOfAdministration
|
subcutaneous
|
|
gptkbp:sideEffect
|
gptkb:hypoglycemia
allergic reactions
injection site reactions
|
|
gptkbp:storage
|
do not freeze
refrigerate before use
|
|
gptkbp:usedFor
|
gptkb:diabetes_mellitus_type_2
diabetes mellitus type 1
|
|
gptkbp:bfsParent
|
gptkb:insulin
|
|
gptkbp:bfsLayer
|
6
|